⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 14, 2024Cancer Causes & ControlOpen Access

Potential interplay between tumor size and vitamin D receptor (VDR) polymorphisms in breast cancer prognosis: a prospective cohort study

Hampus Lindgren David Ademi Christopher Godina Helga Tryggvadottir Karolin Isaksson Helena Jernström

View Full Paper

Ask AI

Bookmark

Share

Abstract

Vitamin D has some anticancer properties that may decrease breast cancer risk and improve prognosis. The aim was to investigate associations between four previously studied VDR SNPs (Taq1, Tru91, Bsm1, and Fok1) and prognosis in different groups of breast cancer patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lindgren et al. (2024) studied this question.

synapsesocial.com/papers/68e792d4b6db64358770430f https://doi.org/10.1007/s10552-023-01845-1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Vitamin D Receptor as a Prognostic Marker in Breast Cancer—A Cohort Study2024 · 9 citations
2Meta-analysis on Vitamin D Receptor TaqI Polymorphism and Breast Cancer Risk2025
3Vitamin D and melanoma: an umbrella meta-analysis of serum levels, dietary intake, and VDR polymorphismsMeta-Analysis · 2026
4Vitamin D receptor is associated with prognostic characteristics of breast cancer after neoadjuvant chemotherapy—an observational study2024 · 2 citations
5Circulating vitamin D status and prognosis in colorectal cancer: a systematic review and meta-analysis with exploratory evidence on vitamin D receptor polymorphismsMeta-Analysis · 2026